Adimmune of Taiwan Readies Flu Vaccine for China

Adimmune, the Taiwanese vaccine maker and CMO, is planning to export its flu vaccines to China. The company’s vaccines have passed an initial evaluation and are now undergoing China clinical trials. Adimmune is the only cGMP manufacturer of vaccines in Taiwan. It uses an egg-based culture to make vaccines for Japanese encephalitis and tetanus in addition to trivalent and H1N1 flu vaccines. More details.... Stock Symbol: (TW: 4142) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.